Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Historical perspective of cell transplantation in Parkinson's disease.

Boronat-García A, Guerra-Crespo M, Drucker-Colín R.

World J Transplant. 2017 Jun 24;7(3):179-192. doi: 10.5500/wjt.v7.i3.179. Review.

2.

Future of cell and gene therapies for Parkinson's disease.

Isacson O, Kordower JH.

Ann Neurol. 2008 Dec;64 Suppl 2:S122-38. doi: 10.1002/ana.21473.

3.

Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease.

Vinuela A, Hallett PJ, Reske-Nielsen C, Patterson M, Sotnikova TD, Caron MG, Gainetdinov RR, Isacson O.

Brain. 2008 Dec;131(Pt 12):3361-79. doi: 10.1093/brain/awn192. Epub 2008 Nov 6.

4.

Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease.

Rodríguez-Gómez JA, Lu JQ, Velasco I, Rivera S, Zoghbi SS, Liow JS, Musachio JL, Chin FT, Toyama H, Seidel J, Green MV, Thanos PK, Ichise M, Pike VW, Innis RB, McKay RD.

Stem Cells. 2007 Apr;25(4):918-28. Epub 2006 Dec 14.

5.

Intracerebral xenografts of human mesencephalic tissue into athymic rats: immunochemical and in vivo electrochemical studies.

Strömberg I, Almqvist P, Bygdeman M, Finger TE, Gerhardt G, Granholm AC, Mahalik TJ, Seiger A, Hoffer B, Olson L.

Proc Natl Acad Sci U S A. 1988 Nov;85(21):8331-4.

6.

Grafted noradrenergic neurons suppress seizure development in kindling-induced epilepsy.

Barry DI, Kikvadze I, Brundin P, Bolwig TG, Björklund A, Lindvall O.

Proc Natl Acad Sci U S A. 1987 Dec;84(23):8712-5.

7.

Transplantation into the human brain: present status and future possibilities.

Lindvall O.

J Neurol Neurosurg Psychiatry. 1989 Jun;Suppl:39-54. Review. No abstract available.

Supplemental Content

Support Center